These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26463642)

  • 1. Systemic cyclosporine and corneal transplantation.
    Ziaei M; Ziaei F; Manzouri B
    Int Ophthalmol; 2016 Feb; 36(1):139-146. PubMed ID: 26463642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical cyclosporine in corneal transplantation.
    Ziaei M; Manzouri B
    Cornea; 2015 Jan; 34(1):110-5. PubMed ID: 25357076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine a drug-delivery system for high-risk penetrating keratoplasty: Stabilizing the intraocular immune microenvironment.
    Zhang T; Li Z; Liu T; Li S; Gao H; Wei C; Shi W
    PLoS One; 2018; 13(5):e0196571. PubMed ID: 29734357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratoplasty postoperative treatment update.
    Shimmura-Tomita M; Shimmura S; Satake Y; Shimazaki-Den S; Omoto M; Tsubota K; Shimazaki J
    Cornea; 2013 Nov; 32 Suppl 1():S60-4. PubMed ID: 24104936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of duration and timing of systemic cyclosporine therapy on corneal allograft survival in a rat model.
    Claerhout I; Beele H; Verstraete A; Van den Broecke C; Kestelyn P
    Graefes Arch Clin Exp Ophthalmol; 2001 Feb; 239(2):152-7. PubMed ID: 11372546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic cyclosporine in high-risk keratoplasty: long-term results.
    Hill JC
    Eye (Lond); 1995; 9 ( Pt 4)():422-8. PubMed ID: 7498559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of high-risk corneal transplantation.
    Di Zazzo A; Kheirkhah A; Abud TB; Goyal S; Dana R
    Surv Ophthalmol; 2017; 62(6):816-827. PubMed ID: 28012874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical corticosteroids with topical cyclosporine A versus topical corticosteroids alone for immunological corneal graft rejection.
    Marques RE; Leal I; Guerra PS; Barão RC; Quintas AM; Rodrigues W
    Eur J Ophthalmol; 2022 May; 32(3):1469-1481. PubMed ID: 34231398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of cyclosporin A absorption for effective immunomodulatory therapy after high-risk keratoplasty].
    Bailly N; Dunewa I; Schlattmann P; Rieck PW
    Ophthalmologe; 2008 May; 105(5):457-62. PubMed ID: 18299847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel cyclosporine a drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: a clinical study.
    Shi W; Chen M; Xie L; Liu M; Gao H; Wang T; Wu X; Zhao J
    Ophthalmology; 2013 Apr; 120(4):695-702. PubMed ID: 23246118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation.
    Shimazaki J; Den S; Omoto M; Satake Y; Shimmura S; Tsubota K
    Am J Ophthalmol; 2011 Jul; 152(1):33-39.e1. PubMed ID: 21570054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new model of corneal transplantation in the miniature pig: efficacy of immunosuppressive treatment.
    Tavandzi U; Procházka R; Usvald D; Hlucílová J; Vitásková M; Motlík J; Vítová A; Filipec M; Forrester JV; Holán V
    Transplantation; 2007 May; 83(10):1401-3. PubMed ID: 17519795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of systemic tacrolimus in high-risk penetrating keratoplasty after graft failure with systemic cyclosporine.
    Yamazoe K; Yamazoe K; Yamaguchi T; Omoto M; Shimazaki J
    Cornea; 2014 Nov; 33(11):1157-63. PubMed ID: 25255133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of postoperative immunosuppression after keratoplasty in herpetic keratitis.
    Maier AK; Ozlügedik S; Rottler J; Heussen FM; Klamann MK; Huber KK; Joussen AM; Winterhalter S
    Cornea; 2011 Dec; 30(12):1398-405. PubMed ID: 21996945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Penetrating keratoplasty in high-risk children: prevention of graft rejection].
    Pleskova AV; Khvatova AV
    Vestn Oftalmol; 2014; 130(3):17-20. PubMed ID: 25098116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
    Price MO; Price FW
    Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of corneal transplantation.
    Ziaei M; Sharif-Paghaleh E; Manzouri B
    Expert Opin Pharmacother; 2012 Apr; 13(6):829-40. PubMed ID: 22424532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic strategies in the prevention and treatment of corneal transplant rejection.
    Tabbara KF
    Int Ophthalmol; 2008 Jun; 28(3):223-32. PubMed ID: 17634865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of corneal allograft rejection on the long-term outcome of corneal transplantation.
    Coster DJ; Williams KA
    Am J Ophthalmol; 2005 Dec; 140(6):1112-22. PubMed ID: 16376660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic cyclosporin A in high failure risk, repeated corneal transplantation.
    Rumelt S; Bersudsky V; Blum-Hareuveni T; Rehany U
    Br J Ophthalmol; 2002 Sep; 86(9):988-92. PubMed ID: 12185123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.